跳至主要内容
临床试验/NCT04336683
NCT04336683已完成不适用

Feasibility Study for Ultrasound-Guided Interstitial Brachytherapy for Gynecological CancersV2

Western University, Canada2 个研究点 分布在 1 个国家目标入组 35 人开始时间: 2015年2月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
35
试验地点
2
主要终点
Efficacy of the 3DUS device to visualize applicators

研究概览

简要总结

Brachytherapy treatment in gynecological cancers is an essential component to delivering adequate doses of radiation to a tumour while sparing normal tissue. Interstitial and intracavitary brachytherapy is often needed in advanced or recurrent disease, in cases where intrauterine brachytherapy may not deliver the optimal outcome. Interstitial brachytherapy is based on a defined template-and-needle system, and the procedure relies on clinical examination and pre-treatment imaging to guide needle insertion. There is currently no standard image-guided process to help direct needles in the pelvis. The investigators propose a 3D ultrasound device that will provide real-time imaging for the brachytherapy procedure which will aid in avoiding needle insertion into pelvic organs and result in optimal dose coverage to the tumour.

详细描述

This is an efficacy study to optimize the use of three-dimensional ultrasound imaging for interstitial and intracavitary brachytherapy. In this study, 3DUS images will be acquired during the regular clinical procedure to assess the quality of the images, anatomical detail and location of needles. The acquired images will be analyzed post-treatment and fused with pre-treatment MRI, and post-treatment CT scans to develop a virtual simulated radiation treatment plan, and to verify the applicator positions.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with locally advanced or recurrent gynecological malignancies who are offered interstitial or intracavitary brachytherapy treatment. These typically would include patients with primary or recurrent vaginal cancers, endometrial cancers or cervical cancers. Histologies of these cancers are typically adenocarcinomas or squamous cell carcinomas

排除标准

  • Above patients who are not offered interstitial or intracavitary brachytherapy as a treatment modality

结局指标

主要结局

Efficacy of the 3DUS device to visualize applicators

时间窗: 16 Weeks

The number of applicators identified within the 3D ultrasound image.

次要结局

  • 3DUS to CT Fusion(16 Weeks)

研究者

发起方
Western University, Canada
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验